The Hybrid Model: A New Pharmacokinetic Model for Computer-Controlled Infusion Pumps

IEEE Transactions on Biomedical Engineering

Volumn 41, Issue 2, 1994, Pages 134-142

  Wada, D Russell ^a,b   Ward, Denham S ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULATION; COMPARTMENT MODEL; COMPUTER SYSTEM; DRUG BLOOD LEVEL; INFUSION PUMP; PHARMACOKINETICS; REVIEW;

ALFENTANIL; COMPUTER SIMULATION; DRUG THERAPY, COMPUTER-ASSISTED; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; MODELS, BIOLOGICAL; PHARMACOKINETICS;

EID: 0028287747     PISSN: 00189294     EISSN: 15582531     Source Type: Journal    
DOI: 10.1109/10.284924     Document Type: Article

References (27)

1. H. Schwilden, “A general method for calculating the dosage scheme in linear pharmacokinetics,” Eur. J. Clin. Pharmacol., vol. 20, pp. 379–386, 1981.
2. J. M. AIvis, J. G. Reves, A. V. Govier, P. G. Menkhaus, C. E. Henling, J. A. Spain, and E. Bradley, “Computer-assisted continuous infusion of the intravenous analgesic fentanyl during general anesthesia—an interactive system,” IEEE Trans. Biomed. Eng., vol. 32, pp. 323–329, 1985.
3. J. R. Jacobs, “Algorithm for optimal linear model-based control with application to pharmacokinetic model-driven drug delivery,” IEEE Trans. Biomed. Eng., vol. 37, pp. 107–109, 1990.
4. J. M. Bailey and S. L. Shafer, “A simple analytical solution to the three-compartment pharmacokinetic model suitable for computer-controlled infusion pumps,” IEEE Trans. Biomed. Eng., vol. 38, pp. 522–525, 1991.
5. J. Dixon, F. L. Roberts, R. M. Tackley, G. T. R. Lewis, H. Connell, and C. Prys-Roberts, “Study of the possible interaction between fentanyl and propofol using a computer-controlled infusion of propofol,” Br. J. Anaesth., vol. 64, pp. 142–147, 1990.
6. P. S. A. Glass, J. R. Jacobs, L. R. Smith, B. Ginsberg, T. J. Quill, S. A. Bai, and J. G. Reves, “Pharmacokinetic model-driven infusion of fentanyl: assessment of accuracy,” Anesthesiol., vol. 73, pp. 1082–1090, 1990.
7. D. B. Raemer, A. Buschman, J. R. Varvel, B. K. Philip, M. D. Johnson, D. A. Stein, and S. L. Shafer, “The prospective use of population pharmacokinetics in a computer-drive infusion system for alfentanil,” Anesthesiol., vol. 73, pp. 66–72, 1990.
8. S. L. Shafer, J. R. Varvel, N. Aziz, and J. C. Scott, “Pharmacokinetics of fentanyl administered by computer-controlled infusion pump,” Anesth., vol. 73, pp. 1091–1102, 1990.
9. M. E. Ausems, J. Vuyk, C. C. Hug, and D. R. Stanski, “Comparison of a computer-assisted infusion versus intermittent bolus administration of alfentanil as a supplement to nitrous oxide for lower abdominal surgery,” Anesthesiol., vol. 68, pp. 851–861, 1988.
10. W. L. Chiou, “Potential pitfalls in the conventional pharmacokinetic studies: Effects of the initial mixing of drug in blood and the pulmonary first-pass elimination,” J. Pharm. Biopharm., vol. 7, pp. 527–536, 1979.
11. W. W. Mapleson, “An electric analogue for uptake and exchange of inert gases and other agents,” J. Appl. Physiol., vol. 18, pp. 197–204, 1963.
12. K. B. Bischoff and R. L. Dedrick, “Thiopental pharmacokinetics,” J. Pharm. Sci., vol. 57, pp. 1346–1351, 1968.
13. L. E. Gerlowski and R. K. Jain, “Physiologically based pharmacokinetic modeling: Principles and applications,” J. Pharm. Sci., vol. 72, pp. 1103–1127, 1983.
14. J. M. Gallo, “Hybrid pharmacokinetic models to described anti-HIV nucleoside brain disposition following parent and prodrug administration in mice,” Pharm. Res., vol. 8, pp. 247–253, 1991.
15. H. J. M. Lemmens, J. G. Bovill, A. G. L. Burm, and P. J. Hennis, “Alfentanil infusion in the elderly,” Anaesthesia, vol. 43, pp. 850–856, 1988.
16. J. Schiittler, S. Kloos, H. Schwilden, and H. Stoeckel, “Total intravenous anaesthesia with propofol and alfentanil by computer-assisted infusion,” Anaesthesia, vol. 43S, pp. 2–7, 1988.
17. K. Taeger, E. Weninger, F. Schmelzer, M. Adt, N. Franke, and K. Peter, “Pulmonary kinetics of fentanyl and alfentanil in surgical patients,” Br. J. Anaesth., vol. 61, pp. 425–434, 1988.
18. S. Bjorkman, D. R. Stanski, D. Verotta, and H. Harashima, “Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats,” Anesthesiol, vol. 72, pp. 865–873, 1990.
19. R. K. Stoelting, Physiology and Pharmacology in Anesthesia Practice. Philadelphia, PA: J. B. Lippincott, 1987, pp. 640–641.
20. W. E. G. Meuldermans, R. M. A. Hurkmans, and J. J. P. Heykants, “Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil, and lofentanil in blood,” Arch. Int. Pharmacodyn. Ther., vol. 257, pp. 4–19, 1982.
21. D. R. Wada, “Open loop control of drug infusion in anesthesia,” Ph.D. Dissertation, Dept, of Elec. Eng., Univ. Calif. Los Angeles, 1991.
22. F. Camu, E. Gepts, M. Rucquoi, and J. Heykants, “Pharmacokinetics of alfentanil in man,” Anesth. Analg., vol. 61, pp. 657–661, 1982.
23. P. O. Maitre, S. Vozeh, J. Heykants, D. A. Thompson, and D. R. Stanski, “Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients,” Anesthesiol, vol. 66, pp. 3–12, 1987.
24. J. C. Scott, D. R. Stanski, “Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation,” J. Pharmacol Exp. Ther., vol. 240, pp. 159–166, 1987.
25. M. E. Ausems, C. C. Hug, D. R. Stanski, and A. G. L. Burm, “Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery,” Anesthesiol, vol. 65, pp. 362–373, 1986.
26. L. C. Siegel, R. G. Pearl, “Noninvasive cardiac output measurement: troubled technologies and troubled studies,” Anesth. Analg., vol. 74, pp. 790–792, 1992.
27. A. C. Guyton, Med. Phys., ed. 8. Philadelphia, PA: W. B. Saunders, 1991, pp. 221–222.